Synthesis of novel morphiceptin analogues modified in position 3 and their binding to μ-opioid receptors in experimental mammary adenocarcinoma

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 18, 2003, Pages 3855-3860

  Janecka, A ^a   Fichna, J ^a   Wiercioch, R ^a   Mirowski, M ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHICEPTIN DERIVATIVE; MU OPIATE RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN MEMBRANE; BREAST ADENOCARCINOMA; CELL MEMBRANE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS LINKING; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; DRUG UPTAKE; FEMALE; LIPOPHILICITY; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; WESTERN BLOTTING;

EID: 0042090367     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00448-6     Document Type: Article

References (36)

1. Thakur M.L. Nucl. Med. Commun. 16:1995;724.
2. Liu S., Edwards D.S., Barrett J.A. Bioconjugate Chem. 8:1997;621.
3. Fichna J., Janecka A. Bioconjugate Chem. 14:2003;3.
4. McAfee J.G., Neumann R.D. Nucl. Med. Biol. 23:1996;673.
5. Reubi J.C. Q. J. Nucl. Med. 41:1997;63.
6. Lamberts S.W., Krenning E.P., Reubi J.C. Endocr. Rev. 12:1991;450.
7. Schally A.V. Cancer Res. 48:1988;6977.
8. De Jong M., Bakker W.H., Krenning E.P., Breeman W.A., van der Pluijm M.E., Bernard B.F., Visser T.J., Jermann E., Behe M., Powell P., Macke H. Eur. J. Nucl. Med. 24:1997;368.
9. Zagon I.S., McLaughlin E.J., Goodman S.R., Rhodes R.E. J. Nucl. Cancer Inst. 79:1987;1059.
10. Scholar E.M., Violi L., Hexum T.D. Cancer Lett. 35:1987;133.
11. Hatzoglou A., Bakogeorgou E., Hatzoglou C., Martin P.M., Castanas E. Eur. J. Pharmacol. 310:1996;217.
12. Chang K.-J., Killian A., Hazun E., Cuatrecasas P., Chang J.-K. Science. 121:1981;75.
13. Chang K.-J., Su I.F., Brent D.A., Chang J.-K. J. Biol. Chem. 250:1985;9706.
14. Brantl V., Teschemacher H., Blasig J., Henschen A., Lottspeich F. Hoppe-Seyler's Z. Physiol. Chem. 360:1979;1211.
15. Janecka A., Fichna J., Mirowski M., Janecki T. Mini Rev. Med. Chem. 2:2002;565.
16. Zadina J.E., Hackler L., Ge L.J., Kastin A.J. Nature. 386:1997;499.
17. Yamazaki T., Ro S., Goodman M., Chung N.N., Schiller P. J. Med. Chem. 36:1993;708.
18. Keller M., Boissard C., Patiny L., Chung N.N., Lemieux C., Mutter M., Schiller P. J. Med. Chem. 44:2001;3896.
19. Yang Y.R., Chiu T.H., Chen C.L. Eur. J. Pharmacol. 372:1999;229.
20. Rapaka R.S. Life Sci. 39:1986;1825.
21. Maneckjee R., Biswas R., Vonderhaar B.K. Cancer Res. 50:1990;2234.
22. Maneckjee R., Minna J.D. Proc. Natl. Acad. Sci. U.S.A. 87:1990;3294.
23. Ard M.D., Goldstein M.N., Nash D.R., Gottlieb D.L. Biochem. Biophys. Res. Commun. 133:1985;60.
24. Kampa M., Bakogeorgu E., Hatzoglou A., Damianaki A., Martin P.M., Castanas E. Eur. J. Pharmacol. 335:1997;255.
25. Scopsi L., Balslev E., Brunner N., Poulsen H.S., Andersen J., Rank F., Larsson L.I. Am. J. Pathol. 134:1989;473.
26. Maneckjee R., Biswas R., Vonderhaar B.K. Cancer Res. 50:1990;2234.
27. Aylsworth C.F., Hodson C.A., Meites J. Proc. Soc. Exp. Biol. Med. 161:1979;18.
28. Prevost G., Provost P., Salle V., Lanson M., Thomas F. Eur. J. Cancer. 29:1993;1589.
29. Mirowski, M.; Świtalska, J.; Wiercioch, R.; Byszewska, E.; Niewiadomski, H.; Michalska, M. Nucl. Med. Commun. 2003, 24, 297.
30. Chen Y., Mestek A., Liu J., Hurley J.A., Yu L. Mol. Pharmacol. 44:1993;8.
31. Ambo A., Murase H., Niizuma H., Ouchi H., Yamamoto Y., Sasaki Y. Bioorg. Med. Chem. Lett. 25:2002;879.
32. Heyl D.L., Mosberg H.I. Int. Pep. Protein Res. 39:1992;450.
33. Mierke D.F., Nossner G., Schiller P.W., Goodman M. Int. J. Pept. Protein Res. 35:1990;35.
34. Yamazaki T., Probsti A., Schiller P.W., Goodman M. Int. J. Pept. Protein Res. 37:1991;364.
35. Solladie-Cavallo A., Schwarz J. Tetrahedron: Asymmetry. 5:1994;1621.
36. Greenwood F.C., Hunter W.M., Glower J.S. Biochem. J. 89:1963;114.